Matt Luther, MD MSCI
banner
drjmluther.bsky.social
Matt Luther, MD MSCI
@drjmluther.bsky.social
Nephrologist, Hypertension specialist, Physician-scientist.
Yes, MRAs can cause mild hyponatremia. Usually not a major issue but can be a factor. I have not seen severe hyponatremia (eg <125) and use a lot.

Aldosterone deficient mice are mildly hyponatremic (inconsistently)
Primary aldosteronism is associated with mild hypernatremia
October 16, 2025 at 5:54 PM
Tolerate if really needed, but taper as BP falls after spironolactone takes effect- usually weeks to 3 months
September 28, 2025 at 4:37 AM
42% sensitivity is what you want in a screening test, right? [sarcasm]
September 24, 2025 at 3:03 PM
almost always lower dose 12.5-25, occasionally higher 50-100mg.
hyperkalemia/CKD > gynecomastia > dysmenorrhea of course can be limiting
July 15, 2025 at 4:45 PM
Yes you should be able to reduce medications after adding Spironolactone.
I withdraw based on other adverse med effects (edema = CCB; K = thiazide/RAASi)

I use this figure in my talks on Resistant HTN...(observational, but holds up imo)

pubmed.ncbi.nlm.nih.gov/11991219/
July 15, 2025 at 4:16 PM
Bring back methyldopa too!
May 30, 2025 at 2:41 AM
Standardized treatment in advance-HTN included thiazide + ARB for all.

Upcoming Launch-HTN uses standard background meds so will be a mix of real world regimens.
Longer term open label followup is ongoing too.
May 30, 2025 at 2:40 AM
I'm gonna guess Geriatrics
May 29, 2025 at 9:06 PM
*in rodents
May 29, 2025 at 1:08 AM
Hyponatremia define here as <135, and also while all patients on a thiazide. Suspect clinically significant hypoNa is much less common.
#NephJC
May 28, 2025 at 5:40 PM
I do not have any inside info- doesn't look like it is being studied in the US, likely due to lack of patent protection. But it appears much less selective than newer agents. It is just R-fadrazole.
May 28, 2025 at 3:38 AM
the bigger issue is - don't block cortisol synthesis, which ramps up ACTH and revs up the steroid pathway and further augments DOC accumulation.
#NephJC

btw @kidneyboy.bsky.social this pathway needs to be taught to our Neph fellows so they can think this problem out like you're doing
May 28, 2025 at 2:11 AM
Indapamide 2.5mg or if previously on HCTZ continue that dose (if I recall correctly).
Plus Olmesartan 40mg in all.
If previously on 3 drugs then Amlodipine 10mg or max tolerated dose used.
#NephJC
May 28, 2025 at 2:08 AM
absolutely.
May 28, 2025 at 2:02 AM
Not sure the numbers are sig different, but I think your rationale is correct. The dose would have been pushed up to 100mg only in the most resistant #NephJC
May 28, 2025 at 1:57 AM
Theoretically:
- it targets the primary issue in many patients- unregulated aldosterone production.
-avoid effect of further elevated Aldo during MRA treatment

Obvs -avoid gynecomastia and off-target effects of Spiro.
For other MRAs it has always been difficult to push dose high enough.
#NephJC
May 28, 2025 at 1:54 AM